• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白毒性与非运动性帕金森病

Alpha Synuclein Toxicity and Non-Motor Parkinson's.

机构信息

Department of Biology, University of Padova, 35131 Padova, Italy.

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

出版信息

Cells. 2024 Jul 27;13(15):1265. doi: 10.3390/cells13151265.

DOI:10.3390/cells13151265
PMID:39120295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11311369/
Abstract

Parkinson's disease (PD) is a common multisystem neurodegenerative disorder affecting 1% of the population over the age of 60 years. The main neuropathological features of PD are the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and the presence of alpha synuclein (αSyn)-rich Lewy bodies both manifesting with classical motor signs. αSyn has emerged as a key protein in PD pathology as it can spread through synaptic networks to reach several anatomical regions of the body contributing to the appearance of non-motor symptoms (NMS) considered prevalent among individuals prior to PD diagnosis and persisting throughout the patient's life. NMS mainly includes loss of taste and smell, constipation, psychiatric disorders, dementia, impaired rapid eye movement (REM) sleep, urogenital dysfunction, and cardiovascular impairment. This review summarizes the more recent findings on the impact of αSyn deposits on several prodromal NMS and emphasizes the importance of early detection of αSyn toxic species in biofluids and peripheral biopsies as prospective biomarkers in PD.

摘要

帕金森病(PD)是一种常见的多系统神经退行性疾病,影响 60 岁以上人群的 1%。PD 的主要神经病理学特征是黑质致密部(SNpc)中多巴胺能神经元的丧失和富含α-突触核蛋白(αSyn)的路易体的存在,这两者都表现出典型的运动症状。αSyn 已成为 PD 病理学中的关键蛋白,因为它可以通过突触网络传播,到达身体的几个解剖区域,导致非运动症状(NMS)的出现,这些症状被认为在 PD 诊断前就普遍存在,并贯穿患者的一生。NMS 主要包括味觉和嗅觉丧失、便秘、精神障碍、痴呆、快速眼动(REM)睡眠障碍、泌尿生殖功能障碍和心血管损伤。本综述总结了最近关于 αSyn 沉积对几种前驱 NMS 的影响的发现,并强调了在生物流体和外周活检中早期检测 αSyn 毒性物种作为 PD 前瞻性生物标志物的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae5a/11311369/3c2d32ea4c90/cells-13-01265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae5a/11311369/8660a35f70b4/cells-13-01265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae5a/11311369/3c2d32ea4c90/cells-13-01265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae5a/11311369/8660a35f70b4/cells-13-01265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae5a/11311369/3c2d32ea4c90/cells-13-01265-g002.jpg

相似文献

1
Alpha Synuclein Toxicity and Non-Motor Parkinson's.α-突触核蛋白毒性与非运动性帕金森病
Cells. 2024 Jul 27;13(15):1265. doi: 10.3390/cells13151265.
2
Neuropathology of α-synuclein in Parkinson's disease.帕金森病中α-突触核蛋白的神经病理学。
Neuropathology. 2022 Apr;42(2):93-103. doi: 10.1111/neup.12812. Epub 2022 Mar 31.
3
α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.α-突触核蛋白 BAC 转基因小鼠表现出类似 RBD 的行为和嗅觉减退:一种前驱性帕金森病模型。
Brain. 2020 Jan 1;143(1):249-265. doi: 10.1093/brain/awz380.
4
Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions.在 seeded α-突触核蛋白包涵体的小鼠中,杏仁核和皮质功能障碍与行为缺陷相关。
Neurobiol Dis. 2020 Feb;134:104708. doi: 10.1016/j.nbd.2019.104708. Epub 2019 Dec 16.
5
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.通过向黑质内注射预先形成的人源α-突触核蛋白寡聚体来模拟帕金森病神经病理学和症状。
Int J Mol Sci. 2020 Nov 12;21(22):8535. doi: 10.3390/ijms21228535.
6
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.MHC 类 II 转录激活因子调节帕金森病体内大鼠模型中种子化的α-突触核蛋白病理和多巴胺能神经退行性变。
Brain Behav Immun. 2021 Jan;91:369-382. doi: 10.1016/j.bbi.2020.10.017. Epub 2020 Oct 22.
7
14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.14-3-3 蛋白减少致病性 α-突触核蛋白的细胞间转移和传播。
J Neurosci. 2018 Sep 19;38(38):8211-8232. doi: 10.1523/JNEUROSCI.1134-18.2018. Epub 2018 Aug 9.
8
Gangliosides, α-Synuclein, and Parkinson's Disease.神经节苷脂、α-突触核蛋白与帕金森病。
Prog Mol Biol Transl Sci. 2018;156:435-454. doi: 10.1016/bs.pmbts.2017.12.009. Epub 2018 Feb 24.
9
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex.纹状体内注射人源α-突触核蛋白寡聚体诱导大鼠认知障碍,与扣带前皮质神经元放电和神经炎症变化有关。
Cells. 2022 Aug 24;11(17):2628. doi: 10.3390/cells11172628.
10
Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles.脑源性和体外接种的α-突触核蛋白纤维表现出不同的生物物理特征。
Elife. 2024 Nov 25;13:RP92775. doi: 10.7554/eLife.92775.

引用本文的文献

1
Neuroprotective propensity of N-(5-chloro-2-hydroxyphenyl)-2-(morpholin-4-yl-methyl) benzamide, an inventive calcineurin inhibitor, in biological models of Parkinson's disease.新型钙调神经磷酸酶抑制剂N-(5-氯-2-羟基苯基)-2-(吗啉-4-基甲基)苯甲酰胺在帕金森病生物学模型中的神经保护倾向
3 Biotech. 2025 Jun;15(6):149. doi: 10.1007/s13205-025-04314-5. Epub 2025 May 2.

本文引用的文献

1
Nigrostriatal Inflammation Is Associated with Nonmotor Symptoms in an Experimental Model of Prodromal Parkinson's Disease.黑质纹状体炎症与前驱期帕金森病实验模型中的非运动症状有关。
Neuroscience. 2024 Jun 21;549:65-75. doi: 10.1016/j.neuroscience.2024.05.011. Epub 2024 May 13.
2
Neuroinflammation and Schizophrenia: New Therapeutic Strategies through Psychobiotics, Nanotechnology, and Artificial Intelligence (AI).神经炎症与精神分裂症:通过心理益生菌、纳米技术和人工智能(AI)的新治疗策略
J Pers Med. 2024 Apr 6;14(4):391. doi: 10.3390/jpm14040391.
3
Elevated α-synuclein levels inhibit mitophagic flux.
α-突触核蛋白水平升高会抑制线粒体自噬通量。
NPJ Parkinsons Dis. 2024 Apr 9;10(1):80. doi: 10.1038/s41531-024-00696-0.
4
Discovery of a Gut Bacterial Metabolic Pathway that Drives α-Synuclein Aggregation.发现一种肠道细菌代谢途径可驱动α-突触核蛋白聚集。
ACS Chem Biol. 2024 Apr 19;19(4):1011-1021. doi: 10.1021/acschembio.4c00095. Epub 2024 Mar 22.
5
Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.肠道微生物群失调及其对α-突触核蛋白和朊病毒蛋白错误折叠的影响:对神经退行性变的影响。
Front Cell Infect Microbiol. 2024 Feb 16;14:1348279. doi: 10.3389/fcimb.2024.1348279. eCollection 2024.
6
Serotonin as a biomarker of toxin-induced Parkinsonism.血清素作为毒素诱导的帕金森病的生物标志物。
Mol Med. 2024 Mar 1;30(1):33. doi: 10.1186/s10020-023-00773-9.
7
α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Ca3.2 calcium signaling in astrocytes.α-突触核蛋白寡聚体增强神经炎症性 NF-κB 活性,并诱导星形胶质细胞中的 Ca3.2 钙信号。
Transl Neurodegener. 2024 Feb 21;13(1):11. doi: 10.1186/s40035-024-00401-4.
8
A general clinical overview of the non-motor symptoms in Parkinson's disease: Neuropsychiatric symptoms.帕金森病非运动症状的一般临床概述:神经精神症状
Int Rev Neurobiol. 2024;174:59-97. doi: 10.1016/bs.irn.2023.11.001. Epub 2024 Jan 15.
9
Phosphorylated α-synuclein deposited in Schwann cells interacting with TLR2 mediates cell damage and induces Parkinson's disease autonomic dysfunction.沉积在与Toll样受体2(TLR2)相互作用的雪旺细胞中的磷酸化α-突触核蛋白介导细胞损伤并诱发帕金森病自主神经功能障碍。
Cell Death Discov. 2024 Jan 26;10(1):52. doi: 10.1038/s41420-024-01824-8.
10
Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia.迟发性精神分裂症中鞘脂水解酶活性及α-突触核蛋白水平的改变
Metabolites. 2023 Dec 31;14(1):30. doi: 10.3390/metabo14010030.